DEFINITIVE PROXY MATERIALS

Company

REGENERON PHARMACEUTICALS, INC.

Filed

May 28, 1997

Period of Report

June 27, 1997

Accession Number

0000889812-97-001264

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →